Sensitivity to operations |
Incorporates into the workflow with ease, whereby providers can document VIONE related interventions as they are making decisions regarding appropriate medication continuation/planned cessation of medications;
Considers EVERY medication within methodology; no medication is excluded from a review as any could lead to AEs; and
Focuses on deprescribing as a solution rather than blaming the original prescriber, accepting that overprescribing and polypharmacy is a known health system issue rarely related to a single HCP.
|
Reluctance to simplify |
Does not make sweeping assumptions about a single medication or medication class as inappropriate; it deals with each patient’s clinical picture individually;
Incorporates shared decision making and captures, transmits, communicates relevant data in simple formats;
Training focuses on patient safety and quality of life, in addition to medication management.
|
Preoccupation with failure |
Staged to become a standard mind-set for polypharmacy, PIM deprescribing practice; every patient could (and should) be evaluated with the VIONE methodology as a standard to prevent any patient from having an AE; and
Going forward, the VIONE Risk Score is a malleable evolving stratification method to identify high-risk patients based on new risk factors identified by experts.
|
Deference to expertise |
Empowers HCPs at all levels in all specialties to focus on deprescribing in polypharmacy situations; and
Patient identification and review can be a team approach, deferring to either the intake nurse, clinical pharmacy specialist, or specialty prescriber depending on the expertise required for the medication.
|
Commitment to resilience |
Designed to address risk factors for poly pharmacy/PIM related AEs; patients who have historical polypharmacy related AEs (falls, emergency department visits, vulnerable patients, aged > 65 years, on > 15 medications, etc), have higher VIONE Risk Scores and thus warrant expedited review to prevent a similar AE in the future.
|